Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Area of Science:

• Oncology
• Surgical Pathology
• Breast Cancer Research

Background:

• Sentinel lymphadenectomy is a precise method for detecting breast cancer metastasis.
• Previous studies indicated low risk of nonsentinel node involvement when sentinel nodes are clear.
• This study investigates the risk of nonsentinel node involvement when sentinel nodes harbor tumor cells.

Purpose of the Study:

• To assess the probability of nonsentinel axillary metastasis in breast cancer patients with confirmed sentinel node metastasis.
• To identify clinical and tumor characteristics influencing nonsentinel node involvement.
• To inform decisions regarding the extent of axillary staging in breast cancer.

Main Methods:

• Analysis of axillary lymphadenectomy data from 157 women with tumor-involved sentinel nodes (1991-1997).
• Evaluation of nonsentinel node involvement based on sentinel node metastasis size and primary tumor characteristics.
• Statistical analysis to determine factors impacting nonsentinel node metastasis.

Main Results:

• Nonsentinel axillary metastasis occurred in 33.5% of cases (53 out of 157).
• Sentinel node metastasis size significantly impacted nonsentinel node involvement: 7% for micrometastasis (< or =2 mm) vs. 55% for macrometastasis (>2 mm).
• Primary tumor size also correlated with an increased rate of nonsentinel node involvement.

Conclusions:

• Small primary tumors with micrometastatic sentinel nodes suggest a low likelihood of further axillary lymph node metastasis.
• Axillary lymph node dissection may be avoidable for patients with T1/T2 lesions and sentinel node micrometastases.
• Consideration for omitting axillary dissection in T1a lesions with sentinel node metastasis is suggested.